Skip to content
LUMING洛铭BIOMEDICAL DATA SCIENCE CONSULTING

APPROACH

Our Approach

Five steps from question to decision-ready delivery. AI speeds up the work, a computational biologist checks every number, and code ships with the report.

Discovery → Validation → Translation

Our work runs in three stages: find a signal in the data, test it with reproducible methods, then turn the result into something an R&D decision can rest on. The last stage matters most. What mechanism does the result point to, and does it support your next decision?

WORKFLOW

Five steps

The output of each step is the input to the next.

  1. 01

    Define the question

    We turn the R&D question into a hypothesis that data can test. "Is this target worth pursuing?" has to become something specific: in which cancer type, compared with what, measured how. If this step is off, no amount of rigor later will fix it.

  2. 02

    Assess the data

    AI-assisted scans of literature and databases, followed by an expert judgment on whether the available data can answer the question. If it can't, we tell you, and we tell you what data you would need.

  3. 03

    Analyze and validate

    Reproducible pipelines, with every number traceable to its source. Predictive models are cross-validated and externally validated.

  4. 04

    Interpret the biology

    We map results back to mechanism and clinical context. A statistically significant difference isn't the end point; we explain what it means biologically and what it changes for the decision.

  5. 05

    Deliver for decisions

    Figures and conclusions built for the meeting room and the data room.

HOW WE WORK

How we work: AI speeds us up. Experts check the work. Everything is reproducible.

In daily useAI-assisted analysis

LLMs and agents help us scan literature and clinical trial databases, generate code and draft reports. A computational biologist checks every number, and every conclusion traces back to its source.

Publishedmachine learning prediction models

Random Forest, SVM, Lasso and nomograms, with cross-validation and external validation. Model code and validation results ship with the report.

Exploratorygenomic foundation models

DNA language models (DNA-LLMs) combined with Hi-C / HiChIP 3D genomics, used to assess the function of non-coding variants and regulatory sequences. We offer this as an exploratory module and label it as such in reports. It is not presented as conclusive evidence.

Hi-C contact map and a GWAS locus

A non-coding GWAS SNP linked through chromatin loops at enhancers E1 and E2 to Gene A.

Illustrative triangular Hi-C contact map above a genome track, showing a non-coding GWAS SNP linked through chromatin loops at enhancers E1 and E2 to Gene A. Synthetic data.
ILLUSTRATIVE · Not real client data

WHAT WE DON'T DO

AI we don't do

  • No black-box predictions. If we can't explain why a model works, we don't deliver it.
  • No promises that "AI will find your target."
  • Client data never goes into public models.

REPRODUCIBILITY

Reproducibility

  • Every number traces back to its source. Each result in a report can be followed to the data and the analysis step that produced it.
  • Code ships with the report. Analysis scripts and model code are part of the deliverable, so your team can check or rerun the work.
  • Validation results ship with the model. Predictive models come with their cross-validation and external validation results.

Test this approach on your question